Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Forrest H Anthony, MD, PhD
Eleison Pharmaceuticals
Study Director - Richard Gorlick, MD
Children's Hospital at Montefiore
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- the Children'S Hospital at Montefiore
The Bronx, New York, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Baylor College of Medicine/texas Children'S Hospital
Houston, Texas, United States
- Primary Children'S Medical Center
Salt Lake City, Utah, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 30 Nov 2018
- Completion
- 30 Nov 2018
- Last update posted
- 7 Aug 2019
- Registered enrollment
- 28
- Registry id
- NCT01650090
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.